Sasha Latypova
Pharmaceutical R&D Expert
Panel: Future Litigation
Sasha Latypova holds a graduate degree in business from Dartmouth College and is a retired pharmaceutical industry research and development executive with twenty-five years of experience in conducting clinical trials. Ms. Latypova co-founded and managed several contract research organizations performing clinical trials for over 60 pharmaceutical companies, including Pfizer, J&J, AstraZeneca, Novartis, GSK and many others. Her area of expertise was in cardiovascular safety evaluation across all therapeutic areas of drug development. She has interacted with the FDA Center for Drug Evaluation and Research (CDER) on behalf of the pharma companies submitting data for drug approvals. Ms. Latypova has conducted an independent investigation into the lack of good manufacturing practice compliance for Covid vaccines, and the role of the Department of Defense in the design and manufacture of these products and other medical countermeasures.
